PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 8, 2026European Heart Journal0 citations

The impact of very highly elevated lipoprotein(a) levels on the early onset, complexity, and extent of coronary artery disease

View Full Paper
CCCasper F. CoerkampKBKaoutar BouhbouhVVV A Verpalen

Key Points

  • This research investigates the link between very high lipoprotein(a) levels and the early onset, complexity, and extent of coronary artery disease (CAD).
  • Assessed lipoprotein(a) levels in 12,437 individuals undergoing lipid profiling.
  • Matched 558 individuals with elevated lipoprotein(a) against 223 controls with low levels by age and sex.
  • Conducted Kaplan-Meier survival analysis to evaluate event-free survival for obstructive CAD.
  • Computed odds ratios for triple vessel disease and SYNTAX-1 score using multivariable logistic regression.
  • Individuals with very high lipoprotein(a) had significantly lower event-free survival for obstructive CAD.
  • Very high lipoprotein(a) levels were linked to a significantly increased odds of triple vessel disease (OR: 2.968).
  • There was a trend towards increased intermediate-to-high SYNTAX-1 score for those with elevated lipoprotein(a) levels (OR: 3.619).

Abstract

Abstract Introduction Coronary artery disease (CAD) remains the leading cause of death worldwide. Lipoprotein(a) Lp(a) has emerged as a potent, independent risk factor for stable CAD. Purpose This study aimed to evaluate the association between elevated Lp(a) and early onset, complexity and extent of CAD, as measured by invasive coronary angiography characteristics, including the synergy between PCI with taxus and cardiac surgery (SYNTAX)-1 score. Methods Lp(a) levels were assessed in 12,437 individuals who underwent lipid profiling between October 2018 and October 2019 at a tertiary. We included 558 individuals with very highly elevated Lp(a) (230 nmol/L), who were 3:1 matched by age and sex to 223 controls with low Lp(a) (≤7 nmol/L). Kaplan-Meier survival analysis was performed to assess event-free survival for detected obstructive CAD, with age as the timescale. Odds ratios (ORs) for triple vessel disease and SYNTAX-1 score were computed using multivariable logistic regression with adjustments for clinical risk factors (age, sex, hypertension, and diabetes). Results Mean age was 57 ± 16 years and 57.4% were male. Kaplan-Meier analysis indicated that individuals with very high Lp(a) levels had a significant lower event-free survival time for detected obstructive CAD (see Figure 1). Very high Lp(a) levels were significantly associated with triple vessel disease (OR: 2.968, 95% CI: 1.122–7.851, p = 0.028). Finally, we observed a trend towards increased reclassification to an intermediate-to-high SYNTAX-1 score in those individuals with very high Lp(a) (OR: 3.619, 95% CI: 0.973–13.469, p = 0.055). Conclusion Patients with very high Lp(a) (230 nmol/L) have shorter CAD-free survival and an increased prevalence of triple vessel disease on invasive coronary angiography. These findings highlight the importance of early Lp(a) measurement with subsequent anatomical testing in those individuals with highly elevated Lp(a), followed by intensive medical management of other risk factors.Kaplan-Meier Curve Baseline Characteristics

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Coerkamp et al. (2025) studied this question.

synapsesocial.com/papers/698828100fc35cd7a8847361https://doi.org/10.1093/eurheartj/ehaf784.1737
Ask AI
Helpful
Bookmark
Share
View Full Paper